Search results for "Myocardial Infarction"
Chinese medicine reduced cardiac events after STEMI, trial finds
The randomized trial found fewer major cardiac and cerebrovascular events at 30 days and one year after ST-segment elevation myocardial infarction (STEMI) in patients given Tongxinluo for a year compared to those who were given a placebo.
https://acphospitalist.acponline.org/archives/2023/10/25/chinese-medicine-reduced-cardiac-events-after-stemi-trial-finds.htm
25 Oct 2023
3-hour troponin level may help rule out NSTEMI in ED patients triaged to observation
A previously proposed cutoff for 3-hour change in high-sensitivity cardiac troponin T of 7 ng/L missed 66.7% of ED patients with non-ST-segment elevation myocardial infarction (NSTEMI), but a cutoff of 15 ng/L combined with a 0/3-hour absolute change of less than 4 ng/L missed less than 1%.
https://acphospitalist.acponline.org/weekly/archives/2021/08/18/3.htm
18 Aug 2021
Studies look at gap between practice and optimal pharmacotherapy after MI
Patients who have had a myocardial infarction (MI) may benefit from lower doses of beta-blockers than those used in clinical trials, and mineralocorticoid receptor antagonists are often not prescribed as recommended.
https://acphospitalist.acponline.org/weekly/archives/2021/07/14/2.htm
14 Jul 2021
High-sensitivity cardiac troponin may be useful for early ruleout of MI
A Scottish study found that length of stay decreased and discharge rates increased when a high-sensitivity cardiac troponin I concentration below 5 ng/L at ED presentation was used to rule out myocardial infarction (MI), although the safety of this strategy could not be proven.
https://acphospitalist.acponline.org/weekly/archives/2021/03/31/3.htm
31 Mar 2021
Risk for death appears higher in STEMI patients without standard modifiable risk factors
Patients, especially women, who presented with ST-segment elevation (STEMI) and did not smoke or have hypertension, diabetes, or hypercholesterolemia had a significantly higher all-cause mortality rate than those with a risk factor in a retrospective Swedish study.
https://acphospitalist.acponline.org/weekly/archives/2021/03/17/4.htm
17 Mar 2021
Risk model assesses function in older patients after hospitalization for acute MI
Five factors, including longer hospital stay and depression, were associated with declines in activities of daily living six months after discharge for a myocardial infarction (MI).
https://acphospitalist.acponline.org/weekly/archives/2020/10/07/4.htm
7 Oct 2020
Combination of biomarkers appears as accurate as troponin plus clinical signs for identifying type 2 MI
Patients with type 2 myocardial infarction (MI) had higher levels of mid-regional pro-atrial natriuretic peptide, C-terminal pro-endothelin-1, mid-regional pro-adrenomedullin, and procalcitonin than patients with type 1 MI.
https://acphospitalist.acponline.org/weekly/archives/2020/09/02/4.htm
2 Sep 2020
No significant effect seen from routine oxygen therapy in normoxic patients with MI
A subgroup analysis of the DETO2X-AMI trial compared death, rehospitalization with myocardial infarction (MI), and heart failure in patients who had low-normal or high-normal oxygen saturation after MI and were assigned to oxygen therapy or ambient air.
https://acphospitalist.acponline.org/weekly/archives/2019/12/18/3.htm
18 Dec 2019
Adding judgment and EKG to troponin better identified unstable angina, but not AMI
Researchers tested the hypothesis that adding additional information to a high-sensitivity cardiac troponin algorithm would improve diagnosis of ED patients with suspected acute myocardial infarction (AMI).
https://acphospitalist.acponline.org/weekly/archives/2019/08/14/4.htm
14 Aug 2019
AHA scientific statement addresses myocardial infarction in the absence of obstructive coronary artery disease
Management of myocardial infarction in the absence of obstructive coronary artery disease should include consideration of emergency supportive care, a working diagnosis for patient evaluation, cardioprotective therapies regardless of cause, and cause-targeted therapies, according to the American Heart Association (AHA).
https://acphospitalist.acponline.org/weekly/archives/2019/04/03/1.htm
3 Apr 2019
Oxygen has no analgesic effect for patients undergoing PCI, study finds
Patients being treated with percutaneous coronary intervention (PCI) for suspected acute myocardial infarction were randomly assigned to either 6 L of oxygen per minute or ambient air in a Swedish trial.
https://acphospitalist.acponline.org/weekly/archives/2018/08/22/3.htm
22 Aug 2018
Rapid rule-out algorithm for NSTEMI deemed safe, effective
Using results from high-sensitivity cardiac troponin testing at arrival and at one hour, researchers were able to rule in or out non-ST-segment elevation myocardial infarction (NSTEMI) in the majority of patients, a prospective study found.
https://acphospitalist.acponline.org/weekly/archives/2018/08/01/2.htm
1 Aug 2018
Haloperidol increases in-hospital mortality after acute MI compared to atypical antipsychotics
The results suggest that atypical antipsychotics may be a less harmful option than haloperidol in older hospital patients with acute myocardial infarction who require an off-label antipsychotic for severe agitation, study authors said.
https://acphospitalist.acponline.org/weekly/archives/2018/04/04/1.htm
4 Apr 2018
Medication adherence rates, outcomes after MI may vary by hospital
Compared to hospitals in the lowest quartile of 90-day composite medication adherence, patients at hospitals with the highest adherence had lower two-year risk of major adverse cardiovascular events.
https://acphospitalist.acponline.org/weekly/archives/2018/02/14/3.htm
14 Feb 2018
Most older patients who smoke do not use prescription medications to quit after MI, study finds
Factors associated with use of bupropion or varenicline after myocardial infarction (MI) included age younger than 75 years, presence of chronic obstructive pulmonary disease or peripheral arterial disease, female sex, and in-hospital revascularization.
https://acphospitalist.acponline.org/weekly/archives/2017/07/26/2.htm
26 Jul 2017
Beta-blockers not associated with lower risk of death after acute MI in patients without heart failure
An accompanying editorial said that the results shouldn't change clinical practice and should be interpreted with “extreme caution” because of the general limitations inherent to observational studies.
https://acphospitalist.acponline.org/weekly/archives/2017/06/07/4.htm
7 Jun 2017
EKG and high-sensitivity troponin T may rule out myocardial infarction
Among chest-pain patients with no new ischemia on an electrocardiogram (EKG) and troponin T below 0.005 µg/L, only 0.5% had an acute myocardial infarction during hospitalization and none died.
https://acphospitalist.acponline.org/weekly/archives/2017/04/19/1.htm
19 Apr 2017
New pathway may rule out more patients, miss fewer MIs than guideline-approved pathway
Researchers compared the safety and efficacy of the European Society of Cardiology rule-out pathway and the new pathway, which incorporates lower cardiac troponin concentrations.
https://acphospitalist.acponline.org/weekly/archives/2017/01/11/1.htm
11 Jan 2017
Medications before transfer worked for patients who had STEMI far from PCI capability
The study compared outcomes among patients who were transferred directly for primary percutaneous coronary intervention (PCI) because they presented within 90 km of the PCI center and those treated with a “pharmaco-invasive strategy” because they were farther away.
https://acphospitalist.acponline.org/weekly/archives/2016/10/05/3.htm
5 Oct 2016
Colchicine treatment associated with reduced inflammation after STEMI
Greek patients who had STEMI treated with PCI were given 6 days of colchicine and showed smaller infarct sizes than similar patients on placebo.
https://acphospitalist.acponline.org/weekly/archives/2015/08/19/4.htm
19 Aug 2015